Inspire Medical Systems (INSP) Common Equity (2017 - 2026)

Inspire Medical Systems has disclosed Common Equity across 10 years of filings, most recently posting $792.3 million for Q1 2026.

• Common Equity for Q1 2026 came in at $792.3 million, up 24.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $792.3 million (up 24.63% YoY), and the FY2025 annual result was $781.2 million, up 13.26% from the prior year.
• Common Equity came in at $792.3 million for Q1 2026 at Inspire Medical Systems, up from $781.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $792.3 million in Q1 2026 to a low of $225.1 million in Q1 2022.
• The 5-year median for Common Equity is $589.0 million (2024), against an average of $572.7 million.
• Across the five-year window, Common Equity surged 133.21% in 2023 and dropped 4.32% in 2025, its largest moves.
• Inspire Medical Systems' Common Equity stood at $496.0 million in 2022, then advanced by 15.42% to $572.5 million in 2023, then advanced by 20.47% to $689.7 million in 2024, then advanced by 13.26% to $781.2 million in 2025, then increased by 1.43% to $792.3 million in 2026.
• The last three Common Equity figures came in at $792.3 million (Q1 2026), $781.2 million (Q4 2025), and $666.5 million (Q3 2025), per Business Quant data.